Cadl Stock Analysis Candel Therapeutics Inc. Biotech At 5 Dollar Level Post Mild Daily Uptick 20260403 1 EYE Q1 2026 Earnings Earnings Beat Estimates Stock Moves Higher Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies MT Bank MTB Q1 2026 Earnings EPS Beat Amidst Stable Loan Activity Pathward Financial Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher Interlink Electronics Q3 2025 Earnings Narrowed Loss Beats Expectations Amid Opaque Revenue Picture RDDT Q1 2026 Earnings EPS Blowout Surprises Wall Street Yet Shares Slide